Results 31 to 40 of about 1,692 (164)

Diagnostics and management of vulvovaginal atrophy according to the international guidelines

Фундаментальная и клиническая медицина, 2022
Vulvovaginal atrophy is one of the genitourinary symptoms caused by estrogen deficiency which leads to the development of immature vaginal epithelium, glycogen deficiency, reduction or even elimination of lactobacilli, and secondary genitourinary tract ...
K. V. Dmitrienko, S. D. Yavorskaya, G. V. Nemtseva   +2 more
doaj   +1 more source

Vulvovaginal atrophy: modern approaches to diagnostics and management

Zaporožskij Medicinskij Žurnal
The aim of the review is to analyze the latest data on the current state of diagnosis and management of a common benign vulvar and vaginal disease in postmenopausal women – atrophic vulvovaginitis.
V. H. Siusiuka, N. V. Avramenko, M. I. Pavliuchenko, M. Yu. Serhiienko, A. O. Kniazieva   +4 more
doaj   +1 more source

Efficacy of laser remodeling in the genitourinary syndrome of menopause: A review

Гинекология, 2023
The real-world treatment of genitourinary syndrome of menopause has several limitations: contraindications to topical estrogen therapy, which is currently recognized as the "gold standard" treatment for vulvovaginal atrophy (VVA), fear of the systemic ...
Mekan R. Orazov, Elena S. Silantyeva, Viktor E. Radzinsky, Liudmila M. Mikhaleva, Elizaveta A. Khripach, Evgeny D. Dolgov   +5 more
doaj   +1 more source

Treatment of postmenopausal vulvovaginal atrophy with estriol: a scientific update for 2014–2018

Акушерство, гинекология и репродукция, 2019
Due to the increase in life expectancy, today, most women live in a state of estrogen deficiency for more than a third of their life time. According to the recent document on the stages of aging of the female reproductive system (the STRAW+10 working ...
A. D. Makatsariya, D. V. Blinov, V. O. Bitsadze, J. Kh. Khizroeva   +3 more
doaj   +1 more source

Ospemifene: A Novel Oral Therapy for Vulvovaginal Atrophy of Menopause [PDF]

Journal of Obstetrics and Gynaecology Canada, 2020
Vulvovaginal atrophy (VVA) resulting from estrogen deprivation at menopause often results in distressing vaginal dryness and dyspareunia. Fewer than 25% of affected women seek help for this condition citing embarrassment, cultural values, an aging or unavailable partner and concerns about use of estrogens following the Women's Health Initiative ...
Robert L. Reid, Denise Black, Christine Derzko, David Portman   +3 more
openaire   +2 more sources

Current approaches to the treatment of vulvovaginal atrophy in women with gynecological and breast cancer

Фармакоэкономика
Background. Treatment of vulvovaginal atrophy (VVA) in women diagnosed with gynecologic or breast cancer presents challenges. Treatment options for VVA, the genital manifestation of the genitourinary syndrome of menopause (GSM), generally mirror those ...
O. S. Gridasova, A. G. Solopova, E. I. Rumyantseva, A. E. Ivanov, D. О. Utkin, J. Kh. Khizroeva   +5 more
doaj   +1 more source

Menopausal hormone therapy and comprehensive postmenopausal care in gynecologic cancer survivors: A position paper from the FIGO Committee on Women at Menopausal Age

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Recent advances in cancer screening, diagnosis, and treatment have greatly improved survival rates among women with gynecologic cancers. More survivors now live long enough to experience treatment‐related menopause. Vasomotor symptoms, genitourinary syndrome of menopause, sexual dysfunction, sleep issues, and long‐term risks from estrogen ...
Agnaldo Lopes da Silva‐Filho, Suvarna Khadilkar, Hema Divakar, Chiara Benedetto, Andrea R. Genazzani, Diana Ramos, Elizabete Argale, Enrique Herrera, Martha Hickey   +8 more
wiley   +1 more source

Potential and perspectives of local application of hyaluronic acid in vulvovaginal atrophy in women of reproductive age: A review

Гинекология
Disruption of the structure and function of the vulvovaginal epithelium in women of reproductive age is accompanied by impaired sexual function and a decrease in the quality of life.
Vera N. Prilepskaya, Niso M. Nazarova, Anastasia R. Devyatkina, Patimat R. Abakarova, Elena A. Mezhevitinova   +4 more
doaj   +1 more source

Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA

Climacteric, 2023
This study aimed to evaluate the self-reported satisfaction of Spanish postmenopausal women currently treated for vulvovaginal atrophy (VVA) symptoms.The CRETA (CRoss sectional European sTudy on Adherence) is a multicenter cross-sectional study conducted in 29 public and private hospitals in Spain, which enrolled postmenopausal women receiving ...
R. Sánchez-Borrego, M. V. de Diego Pérez de Zabalza, M. J. Alfageme Gullón, M. L. Alija Castrillo, M. Sánchez Prieto, S. Palacios, A. J. González Calvo, J. J. Quijano Martín, M. J. Cancelo   +8 more
openaire   +2 more sources

Assessment and management of dyspareunia in peri‐ and postmenopausal women: A phenotype‐based gynecologic approach

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Dyspareunia in peri‐ and postmenopausal women is common, clinically consequential, and often undertreated in gynecologic practice. Although genitourinary syndrome of menopause (GSM) is a frequent contributor, intercourse‐related pain may also reflect vestibular, pelvic floor, dermatologic, inflammatory, treatment‐related, and psychosocial ...
Marek Broul, Marcel Vančo, Jaroslava Banýrová, Aneta Hujová   +3 more
wiley   +1 more source